Evogene Stock Market Value
| EVGN Stock | USD 1.57 0.02 1.29% |
| Symbol | Evogene |
Evogene Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evogene. If investors know Evogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.46) | Revenue Per Share | Quarterly Revenue Growth 0.398 | Return On Assets | Return On Equity |
The market value of Evogene is measured differently than its book value, which is the value of Evogene that is recorded on the company's balance sheet. Investors also form their own opinion of Evogene's value that differs from its market value or its book value, called intrinsic value, which is Evogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evogene's market value can be influenced by many factors that don't directly affect Evogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Evogene 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Evogene's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Evogene.
| 01/02/2025 |
| 02/01/2025 |
If you would invest 0.00 in Evogene on January 2, 2025 and sell it all today you would earn a total of 0.00 from holding Evogene or generate 0.0% return on investment in Evogene over 30 days. Evogene is related to or competes with Arcus Biosciences, Fate Therapeutics, Pluri, Lexaria Bioscience, ZyVersa Therapeutics, Biodexa Pharmaceticals, and Can Fite. Evogene Ltd., together with its subsidiaries, operates as a computational biology company More
Evogene Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Evogene's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Evogene upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 23.77 | |||
| Value At Risk | (6.70) | |||
| Potential Upside | 10.56 |
Evogene Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Evogene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Evogene's standard deviation. In reality, there are many statistical measures that can use Evogene historical prices to predict the future Evogene's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.54) | |||
| Total Risk Alpha | (0.98) | |||
| Treynor Ratio | 1.42 |
Evogene Backtested Returns
Evogene secures Sharpe Ratio (or Efficiency) of -0.0675, which denotes the company had a -0.0675 % return per unit of risk over the last 3 months. Evogene exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Evogene's Mean Deviation of 3.66, variance of 25.17, and Standard Deviation of 5.02 to check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.4, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Evogene are expected to decrease at a much lower rate. During the bear market, Evogene is likely to outperform the market. At this point, Evogene has a negative expected return of -0.34%. Please make sure to confirm Evogene's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Evogene performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.88 |
Very good predictability
Evogene has very good predictability. Overlapping area represents the amount of predictability between Evogene time series from 2nd of January 2025 to 17th of January 2025 and 17th of January 2025 to 1st of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Evogene price movement. The serial correlation of 0.88 indicates that approximately 88.0% of current Evogene price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.88 | |
| Spearman Rank Test | 0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Evogene lagged returns against current returns
Autocorrelation, which is Evogene stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Evogene's stock expected returns. We can calculate the autocorrelation of Evogene returns to help us make a trade decision. For example, suppose you find that Evogene has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Evogene regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Evogene stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Evogene stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Evogene stock over time.
Current vs Lagged Prices |
| Timeline |
Evogene Lagged Returns
When evaluating Evogene's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Evogene stock have on its future price. Evogene autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Evogene autocorrelation shows the relationship between Evogene stock current value and its past values and can show if there is a momentum factor associated with investing in Evogene.
Regressed Prices |
| Timeline |
Pair Trading with Evogene
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evogene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evogene will appreciate offsetting losses from the drop in the long position's value.Moving together with Evogene Stock
| 0.64 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
Moving against Evogene Stock
| 0.64 | EHAB | Enhabit | PairCorr |
| 0.57 | LFCR | Lifecore Biomedical | PairCorr |
| 0.55 | BMY | Bristol Myers Squibb Earnings Call This Week | PairCorr |
| 0.37 | GILD | Gilead Sciences Earnings Call This Week | PairCorr |
| 0.36 | SEM | Select Medical Holdings | PairCorr |
The ability to find closely correlated positions to Evogene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evogene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evogene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evogene to buy it.
The correlation of Evogene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evogene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evogene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evogene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Evogene Correlation, Evogene Volatility and Evogene Alpha and Beta module to complement your research on Evogene. To learn how to invest in Evogene Stock, please use our How to Invest in Evogene guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Evogene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.